Robert Ehrman retweeted
In SAEM's sepsis care in the ED podcast series, brought to you by @BCILifeSciences and @biomerieux, join SAEM members Michael Puskarich and Robert Ehrman as they explore early identification, patient outcomes, and biomarker research.
Listen now: ow.ly/JXPI50Q54WM
What is your favorite R package and why is it @gt_package?
gt `0.10.0` is now out on CRAN. Here are some new features:
- nanoplots, tiny interactive plots
- add columns/rows to your table
- units notation
- the `from_column()` helper
- `fmt_icon()` for adding icons!
The full set of release notes available here: github.com/rstudio/gt/releas….
Retweet= endorsement.
GOD BLESS these authors for studying this topic! Few things I hate more than "well they have a chronic trop leak so NBD".
The significance of historical troponin elevation in acute heart failure: Not as reassuring as previously assumed
@AcademicEmerMed
pubmed.ncbi.nlm.nih.gov/3764….
Robert Ehrman retweeted
Introducing our podcast series on sepsis care in the emergency department, sponsored by @BCILifeSciences and @biomerieux! Join SAEM members Michael Puskarich and Robert Ehrman as they explore early identification, biomarker research, and more.
Listen now: ow.ly/TaZo50PNwqH
change in pulmonary congestion from admission to discharge seems to confer more prognostic info than discharge congestion alone. targets for optimal in-hospital decongestion should be sought. nice new paper from @nickharrison23 et al. sciencedirect.com/science/ar…
Robert Ehrman retweeted
Our Research Subcommittee’s next webinar is Tues 5/30 from 1-2pm EST & will be focusing on statistics! We’re thrilled to have a fantastic panel including @rbcrisp, @nickharrison23, @sonostolz & statistician Timmy Lin! We hope you can join! (Zoom link on EngagED). @fmbrussell
Robert Ehrman retweeted
Dive into the world of #sepsiscare in the emergency department with our new podcast series featuring Dr. Michael Puskarich and Dr. Robert Ehrman.
Episode 3 is available now. Listen today! ow.ly/3Aey50N7EMu
interesting piece about research methods review that will likely meet resistance in some areas. one wonders about the ethics of performing studies that have no possibility of success, even in (or especially in) the absence of overt malfeasance. @KayteSB nature.com/articles/d41586-0…
to the authors who wrote these cherished lines in the closing paragraph of their methods section 🥰😍🥳
Hi @AmtrakAlerts, I’m still stuck on your train. Hours and hours have passed, the train is further delayed, yet still not a single additional update.
Replying to @rbcrisp
Hello, Robert. We're sorry to hear about the delay you're experiencing and apologize for the lack of updates you've received. Train 350 is currently running 1 hour and 12 minutes late due to a delayed exchange of equipment.
Beyond manual creation in power point, what are people using to make digital versions of DAGs/conceptual models/SEMs/etc? #EpiTwitter #StatsTwitter
Robert Ehrman retweeted
Just out @TheLancet
Failure of Molnupiravir to reduce Covid hospitalizations or deaths in a very large randomized trial (N>25,000 participants, mean age 57, 99% vaccinated) thelancet.com/journals/lance…
This is truth, not parody. But def worth a read.
🎄NEW @bmj_latest Christmas article🎄
"On the 12th Day of Christmas, a Statistician Sent to Me..."
Fun & light-hearted, flags common issues the BMJ Stats Editors encounter during peer review
Hoping for a positive educational impact, so please share 🙏
bmj.com/content/379/bmj-2022…
Cancer and suffocation are ending 2022 with a very intense series of high fives…in a sad twist that probably surprises very few.
Robert Ehrman retweeted
I know this thread is way too long so here it is as a blog post:
youcanknowthings.com/2022/12…

















